Item Coversheet

Sarasota County Schools Logo
November 6, 2024 Board Meeting
Agenda Item 37.

Title
APPROVAL OF THE AMENDMENT TO THE EXPRESS SCRIPTS CONTRACT FOR ADDITION OF THE OMADA CHRONIC CONDITION MANAGEMENT PROGRAM EFFECTIVE 02/01/2025

Description
The current medical and pharmacy plan lacks a comprehensive chronic condition management program. The plan currently has approximately 580 members with chronic conditions such as diabetes and hypertension. To address this deficiency, the Omada Lifestyle Management Program through Express Scripts offers resources for diabetes prevention and management, as well as hypertension management. This program utilizes clinical data for personalized care, tracks utilization, and monitors progress. Members benefit from health coaching, digital tools, and connected monitors to better manage their conditions.

Gap Analysis
Currently no chronic condition management program in place. 

Previous Outcomes 
N/A

Expected Outcomes 
Members with chronic conditions will have support in place to help monitor conditions and improve outcomes.  It is expected approximate participation will be 20 – 30%.   There is a ROI of 1.3:1 or about $246,000.

Strategic Plan Goal

Pillar 3 - Every Employee Valued

Priority 1 - Recruit, Recognize, and Retain

Priority 2 - Foster Employee Engagement

 

Pillar 4 - Every School Equipped

Priority 1 - Maintain Sustainable Financial Practices


Recommendation
That the amendment to the Express Scripts contract for the addition of the Omada Chronic Condition Management Program be approved as presented. 

Contact Information

LYNN PETERSON   lynn.peterson@sarasotacountyschools.net

ASHLEY ROMADKA   ashley.romadka@sarasotacountyschools.net



Financial Impact

Omada Prevention: $46 per participating member per month

Omada for Diabetes and Hypertension: $85 per participating member per month.

 

Estimated Financial Impact - $177,480

Source - Internal Service Fund



ATTACHMENTS:
DescriptionUpload DateType
Express Scripts 9149 SCSB Full Omada Clinical Addendum10/18/2024Cover Memo